EURONEXT:BOTHE
Bone Therapeutics
- Stock
Last Close
0.29
26/10 15:35
Volume Today
1.39M
Avg: 201.58K
PE Ratio
−0.26
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -4.08M - | -5.73M 40.57% | -14.14M 146.67% | -12.99M 8.17% | -12.75M 1.82% | -14.22M 11.50% | -10.46M 26.42% | -11.94M 14.14% | -12.93M 8.25% | -2.32M 82.07% | -28.78M 1,141.50% | |
depreciation and amortization | 407K - | 371K 8.85% | 394K 6.20% | 537K 36.29% | 524K 2.42% | 580K 10.69% | 753K 29.83% | 601K 20.19% | 186K 69.05% | 60K 67.74% | 243K 305% | |
deferred income tax | ||||||||||||
stock based compensation | 48K - | 486K 912.50% | 123K 74.69% | -89K 172.36% | 52K 158.43% | -472K 1,007.69% | 266K 156.36% | -99K 137.22% | ||||
change in working capital | 167K - | 1.21M 622.16% | 383K 68.24% | 1.92M 401.31% | 151K 92.14% | -405K 368.21% | -188K 53.58% | 709K 477.13% | -1.31M 284.49% | 219K 116.74% | 1.69M 671.23% | |
accounts receivables | 44K - | 55K 25% | ||||||||||
inventory | ||||||||||||
accounts payables | 175K - | 1.63M 833.71% | ||||||||||
other working capital | ||||||||||||
other non cash items | 231K - | 585K 153.25% | 1.12M 90.77% | -960K 186.02% | 1.15M 219.58% | 1.09M 5.05% | -32K 102.94% | -5.72M 17,768.75% | 1.36M 123.82% | 129K 90.53% | 22.14M 17,066.67% | |
net cash provided by operating activities | -3.27M - | -3.52M 7.64% | -11.77M 233.85% | -11.37M 3.37% | -11.02M 3.09% | -12.90M 17.09% | -10.40M 19.39% | -16.08M 54.63% | -12.78M 20.51% | -1.91M 85.06% | -3.50M 83.14% | |
investments in property plant and equipment | -1.77M - | -3.02M 70.75% | -3.10M 2.51% | -604K 80.52% | -415K 31.29% | -296K 28.67% | -310K 4.73% | -93K 70% | -207K 122.58% | -5K 97.58% | ||
acquisitions net | 12M - | 1.96M - | 6K 99.69% | |||||||||
purchases of investments | -17K - | -24K - | ||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 40K - | 20K 50% | 142K 610% | 26K 81.69% | 1K - | 8K 700% | 2K 75% | 3K 50% | 1K 66.67% | |||
net cash used for investing activites | -1.75M - | -3.00M 71.85% | -2.98M 0.73% | -578K 80.62% | -415K 28.20% | -295K 28.92% | -302K 2.37% | 11.91M 4,043.38% | -204K 101.71% | 1.95M 1,056.86% | 6K 99.69% | |
debt repayment | -135K - | -203K 50.37% | -283K 39.41% | -1.80M 535.34% | -760K 57.73% | -823K 8.29% | -986K 19.81% | -6.61M 570.49% | -2.55M 61.47% | -424K 83.35% | -725K 70.99% | |
common stock issued | 1.49M - | 1.69M 13.35% | 34.62M 1,948.64% | 13.51M - | 8.52M 36.94% | 11.79M 38.42% | 3.29M 72.14% | -22K 100.67% | 1.36M 6,295.45% | |||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 1.28M - | 14.18M 1,003.35% | 2.44M 82.78% | 435K 82.19% | 304K 30.11% | 269K 11.51% | 3.63M 1,248.70% | 5.00M 37.95% | 7.11M 42.08% | 1.49M 79.03% | -138K 109.26% | |
net cash used provided by financing activities | 2.64M - | 15.66M 493.15% | 36.78M 134.80% | -1.36M 103.71% | -456K 66.54% | 12.96M 2,941.67% | 11.16M 13.86% | 10.19M 8.73% | 7.85M 22.94% | 1.04M 86.69% | 1.76M 68.71% | |
effect of forex changes on cash | -1K - | -1K - | 1K - | -1K 200% | 1K 200% | |||||||
net change in cash | -2.38M - | 9.14M 483.59% | 22.03M 141.15% | -13.31M 160.41% | -11.89M 10.68% | -237K 98.01% | 459K 293.67% | 6.01M 1,210.46% | -5.14M 185.42% | 1.09M 121.16% | -1.73M 259.06% | |
cash at beginning of period | 4.82M - | 2.44M 49.40% | 11.58M 374.47% | 33.61M 190.33% | 20.30M 39.60% | 8.41M 58.57% | 8.17M 2.82% | 8.63M 5.62% | 14.65M 69.67% | 759K 94.82% | 1.85M 143.21% | |
cash at end of period | 2.44M - | 11.58M 374.47% | 33.61M 190.33% | 20.30M 39.60% | 8.41M 58.57% | 8.17M 2.82% | 8.63M 5.62% | 14.65M 69.67% | 9.51M 35.08% | 1.85M 80.59% | 117K 93.66% | |
operating cash flow | -3.27M - | -3.52M 7.64% | -11.77M 233.85% | -11.37M 3.37% | -11.02M 3.09% | -12.90M 17.09% | -10.40M 19.39% | -16.08M 54.63% | -12.78M 20.51% | -1.91M 85.06% | -3.50M 83.14% | |
capital expenditure | -1.77M - | -3.02M 70.75% | -3.10M 2.51% | -604K 80.52% | -415K 31.29% | -296K 28.67% | -310K 4.73% | -93K 70% | -207K 122.58% | -5K 97.58% | ||
free cash flow | -5.04M - | -6.55M 29.79% | -14.87M 127.02% | -11.97M 19.46% | -11.43M 4.51% | -13.20M 15.43% | -10.71M 18.85% | -16.18M 51.03% | -12.99M 19.68% | -1.92M 85.26% | -3.50M 82.66% |
All numbers in EUR (except ratios and percentages)